Invitae Finds $120M For Genetic Testing
San Francisco-based Invitae, a provider of genetic testing services for hereditary disorders, said today that it has raised $120M in a funding round. The Series F funding came from The Broe Group, Decheng Capital, Deerfield Management LLC, OrbiMed, Perceptive Advisors, Rock Springs Capital and Wellington Management Company, LLP, along with Casdin Capital, Genesys Capital, Genomic Health, Inc, Randy Scott, Redmile Group and Thomas McNerney & Partners, and others. The company said it will use the new funds to build out its infrastructure and expand globally.
posted on Tuesday, October 14, 2014
Related companies:
Invitae Corp
Related stories:
> Invitae Buys CancerGene Connect For $6M
> Gene Security Network Decodes $6M
> Color Genomics Captures $45M For Genetic Testing For Cancer Risk
> 23andMe Gets $300M From GlaxoSmithKline
> Panomics Acquired By Affymetrix
silicontap.com Home